Abstract. Adenosine kinase (AdK) serves an important role in intracellular adenosine clearance via phosphorylating adenosine to AMP. The role of adenosine and its receptors in the maintenance of bone homeostasis is well studied, particularly in osteoclastogenesis and bone resorption; however, the function of AdK in bone metabolism is still unclear. In the present study, utilizing the cre/floxp recombination system, mice with conditional loss of AdK function in myeloid monocyte cells were used to assess the effect of ADK deficiency on bone metabolism. Mice were evaluated by means of gross observation and bone histomorphometric analysis. Ex vivo osteoclast differentiation and bone resorption were also examined using genetic deletion and pharmacologic inhibition of AdK in osteoclasts. compared with control mice, the results of the present study demonstrate that adult mice lacking AdK in the myeloid monocyte cells had reduced body weight and nasoanal length. The results of bone histomorphometric analysis revealed that bone mass was significantly decreased and osteoclastic parameters were increased in the study mice. Furthermore, in vitro cell culture revealed that inhibition of AdK function promoted osteoclast differentiation and bone resorption. Osteoclast-associated gene expression, including tartrate-resistant acid phosphatase, nuclear factor of activated T-cells, cytoplasmic 1, matrix metalloproteinase 9, Cathepsin K and calcitonin receptor, was also significantly increased. These results suggest that mice with ADK deficiency have reduced bone formation due to increased osteoclastogenesis and bone resorption. The present study provides further insight into the mechanism by which AdK serves a key role in bone metabolism.
Introduction
Adenosine kinase (AdK) is the key metabolic regulator of the purine ribonucleoside adenosine and is essential for intracellular adenosine metabolic clearance via phosphorylating adenosine to AMP based on its low Km (1) . ADK is expressed in most vital organs that require metabolic adenosine clearance, in particular the liver and placenta (2) . AdK controls specific organ functions via a combination of adenosine receptor-dependent and -independent mechanisms (1) . changes in adenosine homeostasis may activate the four adenosine-associated G-protein-coupled receptors, alter energy metabolism and regulate dNA methylation (3) . A number of studies have demonstrated that AdK serves important roles in several diseases, including epilepsy (4), traumatic brain injury (5), stroke (6) , diabetes (7) and cancer (8) .
Bone is a highly dynamic organ that is constantly undergoing remodeling by means of bone formation and resorption in the adult skeleton (9) . Previous studies have investigated the role of adenosine and its four G protein-coupled receptors in the maintenance of bone homeostasis in vivo and in vitro, particularly adenosines association with osteoclastogenesis and bone resorption in rodents and humans (10) . Previous reports suggest that activating adenosine A 1 receptor (A1R) and adenosine A 2B receptor (A2BR) promotes osteoclastogenesis; however, adenosine A 2A receptor (A2AR) activation has the opposite effect (11) (12) (13) (14) and adenosine A 3 receptor (A3R) activation indirectly inhibits osteoclastogenesis due to its anti-inflammatory effect (15) .
ADK deficiency results in the accumulation of intracellular adenosine and a decrease in AMP, AdP and ATP, which in turn leads to disordered purinergic signaling (1) . A recent clinical investigation based on next generation sequencing revealed that patients deficient in AdK with intellectual disabilities also presented with short stature, frontal bossing and slender hands and fingers (16) . In a mouse model, genetic deletion of AdK resulted in mice succumbing within 14 days of birth whereas mice with ADK deficiency exhibited reduced body weight and length (17) . However, the function of AdK in bone metabolism is still unknown.
Osteoclasts are the primary bone-resorbing cells and are thought to be derived from the monocyte-macrophage lineage (18) . In the present study, a mouse model with AdK knockout in myeloid monocyte cells (AdK MMc-KO ) was established via Cre/LoxP site-specific recombination. The effect of AdK on bone metabolism was assessed by gross observation and bone histomorphometric analysis in vivo to ascertain whether there were changes in bone homeostasis. In addition, osteoclast differentiation and bone resorption were examined in vitro by genetic deletion and pharmacologic inhibition of AdK in osteoclasts. Cell culture. Murine osteoclasts were generated from bone marrow cells as previously described (21) . Briefly, following cO 2 euthanasia, primary AdK MMc-KO or AdK WT mouse bone marrow cells were isolated by flushing the tibia and femur of 2-month-old male mice with α-modified Eagle's medium (α-MEM; Thermo Fisher Scientific, Inc., Waltham, MA, USA). Cells were subsequently centrifuged (1,000 x g) at 4˚C for 5 min and incubated in α-MEM containing 10% (v/v) fetal bovine serum (Thermo Fisher Scientific, Inc.), penicillin-streptomycin (100 U/ml) and 1% (w/v) glutamine (Sigma Aldrich; Merck KGaA, darmstadt, Germany) overnight at 37˚C in a humidified atmosphere containing 5% CO 2 . To generate bone marrow-derived macrophages, non-adherent cells were collected, plated onto 24-well plates (1x10 6 cells/well) and cultured at 37˚C in a humidified atmosphere containing 5% CO 2 with 25 ng/ml macrophage colony-stimulating factor (M-cSF; R&d Systems, Inc., Minneapolis, MN, USA) for 3 days in α-MEM. cells were then used for osteoclast differentiation or AdK western blot analysis. To generate osteoclasts, bone marrow-derived macrophages were incubated at 37˚C in a humidified atmosphere containing 5% CO 2 with α-MEM containing 25 ng/ml M-cSF and 30 ng/ml receptor activator of nuclear factor kappa-Β ligand (RANKL; R&D Systems, Inc.) for 5 days. To evaluate the effect of AdK inhibition on osteoclast differentiation, ABT-702 dihydrochloride (Tocris; Bio-Techne, Minneapolis, MN, USA), a potent non-nucleoside ADK inhibitor, was pre-dissolved in 5% EtOH and the solution was diluted with osteoclast differentiation medium as described for cell culture. All assays were performed in triplicate.
Materials and methods

Animals
Western blotting. Total protein was extracted from bone marrow-derived macrophages using radioimmunoprecipitation assay buffer (Sigma Aldrich; Merck KGaA) according to the manufacturer's protocol. Protein was quantified using a bicinchoninic acid assay and 20 µg samples were separated by 10% SDS-PAGE and transferred onto nitrocellulose membranes. The membranes were blocked with 5% (w/v) non-fat dry milk in TBST buffer for 1 h at 4˚C. Rabbit monoclonal antibodies against AdK (Sigma Aldrich; Merck KGaA; cat no. SAB2701969; 1:1,000) and GAPDH (Sigma Aldrich; Merck KGaA; cat. no. G9545, 1:2,500) were used to assess AdK protein levels in cultured cell lysates. The membranes were incubated with the primary antibodies in 1% bovine serum albumin (Sigma Aldrich; Merck KGaA) overnight at 4˚C and washed three times with TBST. Subsequently, membranes were incubated with horseradish peroxidase-conjugated secondary goat anti rabbit antibody (Invitrogen; Thermo Fisher Scientific, Inc.; cat. no. 31460; 1:2,000) in non-fat dry milk for 1 h at room temperature and washed three times with TBST. Membranes were visualized using West Pico chemiluminescent Substrate (Thermo Fisher Scientific, Inc.). Bands were quantified using Image Lab 5.0 (Bio-Rad Laboratories, Inc., Hercules, cA, USA).
Tartrate-resistant acid phosphatase (TRAP) activity assay.
TRAP staining was performed using an Acid Phosphatase Leukocyte (TRAP) kit (Sigma Aldrich; Merck KGaA) according to the manufacturer's protocol. Briefly, osteoclasts differentiated from bone marrow cells were fixed in 37% formaldehyde for 30 sec at 4˚C and rinsed thoroughly in deionized water. TRAP staining solution was mixed and preheated to 37˚C and the fixed cells were added and incubated for 1 h at 37˚C. Cells were counterstained with hematoxylin for 30 sec at room temperature and the number of osteoclasts (defined as multinuclear TRAP-positive cells) per well was counted under a bright field inverted microscope (magnification, x200; DMI3000; Leica Microsystems GmbH, Wetzlar, Germany).
Bone resorption assay and assessments. A bone resorption assay was performed as previously described (22) . Briefly, bone marrow-derived macrophages (1x10 6 cells/well) were seeded in Osteo-Assay Surface 24-well plates (Sigma Aldrich; Merck KGaA); osteoclastic differentiation and culture were performed as above. Plates were examined under a bright field inverted microscope (magnification, x10) and images of 10 random fields/well were captured. The percentage and number of resorption areas were calculated using with ImageJ software 1.50i (National Institutes of Health, Bethesda, Md, USA).
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Total RNA was extracted from cultured cells using TRIzol (Invitrogen; Thermo Fisher Scientific, Inc.) and RT was performed using the PrimeScript™ RT reagent kit (Takara Bio, Inc., Otsu, Japan) at 37˚C for 30 min and 85˚C for 1 min according to the manufacturer's protocol. All primers were provided by Invitrogen (Thermo Fisher Scientific, Inc.) and were as follows: TRAP, forward 5'-ACC ATT GTT AGc cAc ATA cG-3' and reverse 5'-GTG AAA ccG CAA GTA GCC-3; matrix metalloproteinase-9 (MMP-9), forward 5'-AGT TTG GTG TcG cGG AGc Ac-3' and reverse 5'-TAc ATG AGc GcT Tcc GGc Ac-3'; nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1), forward 5'-GGG TcA GTG TGA ccG AAG AT-3' and reverse 5'-GGA AGT cAG AAG TGG GTG GA-3'; proto-oncogene tyrosine-protein kinase Src (c-Src), forward 5'-ccA GGc TGA GGA GTG GTA cT-3' and reverse 5'-cAG cTT GcG GAT cTT GTA GT-3'; FBJ osteosarcoma oncogene (c-FOS), forward 5'-ccA GTc AAG AGc ATc AGc AA-3' and reverse 5'-AAG TAG TGc AGc ccG GAG TA-3'; cathepsin K (ctsK), forward 5'-GAA GAA GAc TcA ccA GAA GcA G-3' and reverse 5'-Tcc AGG TTA TGG GcA GAG ATT-3'; calcitonin receptor (cTR), forward 5'-ccT GAc AGc AAc cGA Acc-3' and reverse 5'-GcA Acc AAA GcA GcA ATc-3'; GAPdH, forward 5'-TGT AGA ccA TGT AGT TGA GGT cA-3' and reverse 5'-AGG TcG GTG TGA AcG GAT TTG-3'. qPCR reactions were performed as follows: 95˚C for 30 sec followed by 40 cycles of 95˚C for 5 sec and 60˚C for 34 sec, using an ABI-7500 Fast Real-Time PcR System (Applied Biosystems; Thermo Fisher Scientific, Inc.) in a total volume of 25 µl containing 2 µM primers and 12.5 µl of the SYBR ® Premix Ex Taq™ (Takara Bio, Inc.). Results were quantified using the 2 -∆∆cq method (23) .
Bone histomorphometric analysis. The proximal tibia metaphysis and tibia shaft were fixed at 4˚C for 48 h in 4% paraformaldehyde and decalcified in 10% EDTA for 3-4 weeks. Tibias were subsequently embedded in paraffin and cut into 4-µm sections. Following deparaffinization and rehydration, sections were stained with hematoxylin and eosin (H&E) for 1 min at room temperature. Terminology recommended by the Histomorphometry Nomenclature committee of the American Society for Bone and Mineral Research (24) and the BIOQUANT OSTEO 2009 morphometric measuring system (Bioquant Image Analysis corporation, Nashville, TN, USA) were used in the present study. The proximal tibia metaphysis histomorphometric perimeters were determined by measuring the areas under 1-3 µm from the growth plate excluding the primary spongiosa and trabeculae connected to the cortical bone. The lower end of the tibia was separated from the fibula and prepared for tibia shaft transection and histomorphometric perimeters were determined.
Statistical analysis. Two-tailed unpaired t-tests with Welch's correction were used for comparisons between the two groups, using GraphPad Prism 6.01 (GraphPad Software, Inc., La Jolla, cA, USA). data are presented as the mean + standard error of the mean of three independent experiments. P<0.05 was considered to indicate a statistically significant difference.
Results
Spontaneous dwarfism in ADK MMC-KO mice. Primordial dwarfism was observed in ADK
MMc-KO mice. compared with male AdK WT mice, the appearance of AdK MMc-KO mice was not markedly different, however the mice appeared markedly smaller at 4 months old (Fig. 1A) . Measurements revealed that the body weight and nasoanal length of AdK MMc-KO mice was significantly decreased compared with AdK WT mice (P<0.0001; Fig. 1B) .
To investigate whether the dwarfism observed in AdK MMc-KO mice was associated with skeletal growth, the tibia and femur were assessed. The results demonstrated that the tibia and femur lengths were significantly shorter in AdK MMc-KO mice compared with AdK WT mice (P<0.0001; Fig. 1c) . Furthermore, it was demonstrated that the tibia and femur weigh significantly less in ADK MMc-KO mice compared with AdK WT mice (P<0.0001; Fig. 1D ). These results suggest that conditional AdK knockout in myeloid monocyte cells causes skeletal dysostosis in mice.
Abnormal bone formation in ADK
MMC-KO mice. To further investigate the causes of skeletal dysostosis in AdK MMc-KO mice, bone samples underwent histomorphometric analysis. In the proximal tibia metaphysis, fewer bone trabeculae and a smaller volume of trabecular bones was observed in AdK MMc-KO mice compared with AdK WT mice ( Fig. 2A ). Quantitative analysis of bone trabecular parameters revealed that the bone area (%Tb.Ar; P<0.01), trabecular thickness (Tb.Th; P<0.05) and trabecular number (Tb.N; P<0.05) were significantly decreased in ADK MMc-KO mice compared with AdK WT mice (Fig. 2B) . Furthermore, trabecular separation (Tb.Sp; P<0.05) was significantly increased in ADK MMc-KO mice compared with AdK WT mice (Fig. 2B) . Analysis of osteoclastic parameters revealed that the percentage of trabecular osteoclast surface to bone surface (%Oc.S/BS; P<0.01) and ratio of osteoclast number to bone surface (N.Oc/BS; P<0.01) were significantly increased in ADK MMc-KO mice compared with AdK WT mice (Fig. 2B) . However, the adherent perimeter of osteoblasts (%Ob.S/BS; P<0.01) and number of osteoblasts per unit bone surface (N.Ob/BS; P<0.01), were significantly lower in in AdK MMc-KO mice compared with AdK WT mice (Fig. 2B) .
The tibial shaft of in AdK MMc-KO mice was also examined and, compared with AdK WT mice, the cortical bone was markedly reduced and an expansive bone marrow cavity was observed (Fig. 2c) . Quantitative analysis revealed that the percentage of cortical bone area was significantly decreased (%Ct.Ar, P<0.01) and the bone marrow cavity area was significantly increased (%Ma.Ar; P<0.01) in ADK MMc-KO mice (Fig. 2d) . These results suggest that conditional AdK knockout in myeloid monocyte cells causes defective bone formation in AdK MMc-KO mice. (Fig. 3A, P<0 .001). BMMs were subsequently exposed to M-CSF and RANKL for 8 days to induce osteoclastic differentiation. A TRAP assay was performed to reveal TRAP-positive cells and the typical multinucleated characteristics of in vitro differentiated osteoclasts were observed (Fig. 3B) . Notably, larger TRAP-positive osteoclasts were observed in AdK MMc-KO cultures compared with those from AdK WT mice (Fig. 3B) . It was also demonstrated that BMMs derived from AdK MMc-KO mice formed significantly more osteoclasts compared with those derived from AdK WT mice (P<0.01; Fig. 3B ). Factors associated with osteoclast formation were evaluated using RT-qPcR and the results indicated that relative levels of TRAP (P<0.01) and NFATc1 (P<0.05) mRNA were significantly increased in AdK MMc-KO osteoclasts compared with AdK WT osteoclasts (Fig. 3C) ; however, no significant difference was observed in c-FOS expression (Fig. 3C) .
To further verify the role of AdK in osteoclast formation, the AdK inhibitor ABT-702 was applied to BMMs from AdK WT mice to induce osteoclastic differentiation (Fig. 3d) . Treatment with 100 nM ABT-702 significantly induced TRAP-positive osteoclast formation compared with untreated AdK WT BMMs (P<0.01; Fig. 3D ). The expression of TRAP (P<0.05) and NFATc1 (P<0.05) mRNA was significantly increased by treatment with 100 nM ABT0702 compared with untreated AdK WT BMMs, similar to AdK MMc-KO cultures (Fig. 3E) . These results suggest that AdK inhibition induces osteoclast formation.
ADK inhibition increases osteoclastic resorption activity.
To investigate whether AdK inhibition affects osteoclastic resorption function, BMMs derived from 2-month-old male AdK WT and AdK MMc-KO mice were incubated with M-cSF and RANKL. Following 7 days of culture, the resorption area of osteoclasts induced from AdK MMc-KO BMMs was significantly greater than that of osteoclasts induced from AdK WT BMMs (P<0.05; Fig. 4A) . Similarly, the number of resorption areas per well was significantly greater in the ADK MMc-KO group compared with the AdK WT GROUP (P<0.05; Fig. 4A ). Factors associated with osteoclast formation were further evaluated in these cultures using RT-qPcR the results demonstrated that relative levels of MMP9 (P<0.01), CtsK (P<0.001) and CTR (P<0.01) mRNA were significantly increased in ADK MMc-KO osteoclasts compared with AdK WT osteoclasts (Fig. 4B) . However, no significant difference was observed in c-Src expression (Fig. 4B) .
BMMs derived from AdK WT mice were also treated with 100 nM ABT-702 to further evaluate the effect of AdK inhibition on osteoclastic resorption. The relative resorption area (P<0.001) and number of resorption areas per well (P<0.01) was significantly increased in cells treated with ABT-702 compared with untreated BMMs derived from AdK WT mice (Fig. 4C) . The relative expression of MMP9 (P<0.01) and CtsK (P<0.05) mRNA was significantly increased in ABT-702 cultures compared with untreated BMMs derived from AdK WT mice (Fig. 4D) . However, no significant difference was observed in c-Src and cTR levels (Fig. 4d) . These results suggest that AdK inhibition may promote osteoclastic resorption activity
Discussion
In the present study, a mouse model with AdK deficient myeloid monocyte cells (AdK MMc-KO ) was established by Cre/LoxP site-specific recombination. As a result of this conditional ADK knockout, spontaneous dwarfism associated with decreased bone mass was observed in adult mice. Further in vitro investigations based on genetic and pharmaceutical AdK disruption in bone marrow macrophages revealed that ADK inhibition significantly increases osteoclastogenesis and bone resorption in mouse BMMs. collectively, these results suggest that AdK may be a potential target for the treatment of metabolic bone diseases associated with osteoclast.
Previous clinical studies have reported that human patients with global ADK deficiency due to homozygous point mutations exhibit developmental delay, including short stature, frontal bossing and slender hands and fingers (16, 25) . A study involving homozygous disruption of the AdK gene in mice also reported reduced body size and weight within a few days of birth (1) . In the present study, AdK
MMc-KO mice were characterized by spontaneous dwarfism, including reduced body weight, nasoanal length, and weight and length of tibia and femur. Histomorphometric analysis revealed significantly decreased bone mass in proximal tibia metaphysis and the middle of the tibial shaft in AdK MMc-KO mice. combined with previous reports, these results indicate that AdK may serve an important role in bone metabolism homeostasis.
Osteoclasts are highly specialized cells that are derived from the monocyte/macrophage lineage of the bone marrow (26) . lysM cre mice have been used extensively to investigate osteoclast function in previous studies (27) (28) (29) . In the present study, osteoclastic changes in AdK MMc-KO mice were assessed in vivo using histomorphometric analysis and in vitro using a BMM cell culture. The results revealed increased osteoclastic parameters, including osteoclastogenesis and bone resorption, associated with ADK deficiency. Histomorphometric analysis also demonstrated that the function of osteoblasts derived from pluripotent mesenchymal stem cells was inhibited in AdK MMc-KO mice, suggesting that purinergic signaling from ADK-deficient activated osteoclasts may affect osteoblasts by interacting with adenosine receptors (10) . Furthermore, the exosomes derived from activated osteoclasts may also inhibit osteoblast activity (30) .
AdK converts intracellular adenosine to AMP; AdK deficiency or dysfunction results in the accumulation of intracellular adenosine (1) . Adenosine may be transported to the extracellular environment by type 1 equilibrative nucleoside transporter (ENT1) (31) ; as such, the ADK-deficiency-induced accumulation of intracellular adenosine may result in adenosine being transported to the extracellular environment by ENT to interact with adenosine receptors, including A1R (32, 33) and A2BR (34, 35) , to promote osteoclast differentiation. However, mice lacking ENT1 have been reported to have reduced weight and lower bone density in the spine and femur associated with increased osteoclast activity (36) . This suggests that intracellular adenosine may also participate in the functional regulation of osteoclasts via a receptor independent pathway, although this requires further investigation.
Metabolic analysis of liver tissue homogenates from homozygous ADK deficient mice revealed a 40% decrease in AMP and ADP and a 35% decrease in ATP (17) . A previous study utilizing osteoclast-specific conditional knockout Tfam mice, in which ATP production is inhibited in osteoclasts, reported reduced growth and increased bone-resorption (37) . An in vitro study demonstrated that ATP inhibits the differentiation of osteoclast-like cells from RANKL-induced RAW cells (38) . A number of studies have reported that metformin is able to effectively improve osteoporosis in patients with long-term type 2 diabetes mellitus by inhibiting osteoclast differentiation (39) (40) (41) . The mechanism by this is achieved is associated with the activation of AMP-activated protein kinase (AMPK), a 'metabolic master switch' downstream of AdK (42) (43) (44) . It was therefore speculated that prolonged ADK deficiency in myeloid monocyte cells may result in disordered purinergic signaling, which may contribute to bone growth retardation and excessive osteoclast differentiation and activation in AdK MMc-KO mice. In summary, the results of the present study suggest that AdK deficient myeloid monocyte cells contribute to reduced bone formation in mice and this is associated with osteoclastogenesis and bone resorption in AdK MMc-KO mice.
